Search alternatives:
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11621
Desilication of ZSM-5 and ZSM-12 Zeolites with Different Crystal Sizes: Effect on Acidity and Mesoporous Initiation
Published 2019“…<div><p>In the present work, the desilication of the H-ZSM-5 and H-ZSM-12 zeolites with Si/AL ratios of 28 and 56 and crystal sizes of around 200 and 600 nm, respectively, was performed. …”
-
11622
-
11623
Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials
Published 2025“…Selective deposition and encapsulation of nanodispersed multiwalled carbon nanotubes (MWCNT) exclusively within polybutylene adipate terephthalate (PBAT) microdomains in a phase-separated microstructure of 80/20 polylactic acid (PLA)/PBAT polymer nanocomposites (PNCs) were achieved by a three-step processing strategy. …”
-
11624
Rab1A knockdown exacerbated stress damage due to serum depletion and 5-FU treatment.
Published 2014“…FU, 5-fluorouracil.</p>…”
-
11625
-
11626
-
11627
-
11628
-
11629
A R13A point mutation in C4 attenuates CLCuMuV infection.
Published 2018“…<i>eIF4α</i> was used as an internal control. Values represent means ± SE from three independent experiments. <b>(C)</b> The mutant CLCuMuV carrying C4<sup>R13A</sup> (CLCuMuV-C4<sup>R13A</sup>), which contains a R13A mutation in <i>C4</i>, showed the decreased viral symptom compared to wild type CLCuMuV. …”
-
11630
-
11631
Data set.
Published 2025“…LA decreased HIV-1 virion-associated RNA levels by ∼50% compared to untreated virus (p < 0.001), acetic acid or HCl acidified media. …”
-
11632
-
11633
-
11634
CD44v6 is required for the growth of BTSC in CD44<sup>high</sup> GBM.
Published 2011“…B: Treatment with siRNA decreased the expression of CD44v6 in both neurosphere (left panel) and serum-propagated CD44<sup>high</sup> GBM (middle panel). …”
-
11635
-
11636
-
11637
Spatial expression pattern of proBcMF26a: GUS-GFP.
Published 2015“…<p>(A–L) Histochemical GUS assays of the T<sub>2</sub><i>Arabidopsis</i> transformed with pBGWFS7.0–proBcMF26a: GUS-GFP vector. …”
-
11638
-
11639
Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
11640
Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”